An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin's lymphoma previously treated with interferon

Endri Mauro, Mariangela Pedata, Anna Ermacora, Cesare Mazzaro

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)101-103
Number of pages3
JournalBlood Transfusion
Issue number1
Publication statusPublished - 2012


  • Non-Hodgkin's lymphoma
  • Pegylated interferon
  • Rituximab
  • Type II mixed cryoglobulinaemia

ASJC Scopus subject areas

  • Hematology
  • Immunology and Allergy

Cite this